M. D. Hamon
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Transplantation top 10%
Papers in
-
- Hematopoietic Stem Cell Transplantation 3
- Acute Myeloid Leukemia Research 1
- Chronic Myeloid Leukemia Treatments 1
- Oncology 3
- Co-authors
- H. G. Prentice (4 shared papers)A. V. Hoffbrand (2 shared papers)Owen Smith (2 shared papers)Paul McWhinney (1 shared paper)C Kibbler (1 shared paper)L. A. Berger (1 shared paper)R.K. Walesby (1 shared paper)Joseph Kearney (1 shared paper)
- Journals
- The Lancet (2 papers)Clinical Infectious Diseases (1 paper)Journal of Clinical Pharmacy and Therapeutics (1 paper)Leukemia & lymphoma (1 paper)PubMed (3 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
M. D. Hamon
8 papers receiving 409 citations
Peers
Comparison fields: 5 of 56
- Hematology 175
- Transplantation 18
- Infectious Diseases 116
- Oncology 118
- Small Animals 26
Countries citing papers authored by M. D. Hamon
This map shows the geographic impact of M. D. Hamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. D. Hamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. D. Hamon more than expected).
Fields of papers citing papers by M. D. Hamon
This network shows the impact of papers produced by M. D. Hamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. D. Hamon. The network helps show where M. D. Hamon may publish in the future.
Co-authors
The 25 scholars most cited alongside M. D. Hamon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 141 | |
| 2 | 1993 | 140 | |
| 3 | 1994 | 48 | |
| 4 | Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. | 1991 | 35 |
| 5 | Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. | 1991 | 31 |
| 6 | Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease. | 1993 | 23 |
| 7 | 1993 | 8 | |
| 8 | 1987 | 3 |
About M. D. Hamon
M. D. Hamon is a scholar working on Hematology, Oncology, Surgery, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 8 papers that have together received 429 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Nausea and vomiting management (1 paper), Antifungal resistance and susceptibility (1 paper), Liver physiology and pathology (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (175 citations), Transplantation (18 citations), Infectious Diseases (116 citations), Oncology (118 citations) and Small Animals (26 citations). M. D. Hamon has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include H. G. Prentice, A. V. Hoffbrand, Owen Smith, Paul McWhinney, C Kibbler, L. A. Berger, R.K. Walesby, Joseph Kearney, Donald McCarthy and M V Joyner. Their work appears in journals such as The Lancet, Clinical Infectious Diseases, Journal of Clinical Pharmacy and Therapeutics, Leukemia & lymphoma and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.